- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Aurobindo Pharma Limited — Updates, 05-08-2026: Press Release
05-08-2026 | 08:00 pm
05-08-2026 | 08:00 pm
Aurobindo Pharma reported strong Q1FY27 results: Revenue rose 16.3% YoY to ₹9,150 Cr, with Net Profit up 25.2% to ₹1,032 Cr. Key markets like Europe (+25.6%) and Growth Markets (+37.7%) drove growth. Company received 10 USFDA product approvals.
No comments yet. Be the first to comment!